产品说明书

UNC2025

Print
Chemical Structure| 1429881-91-3 同义名 : -
CAS号 : 1429881-91-3
货号 : A321872
分子式 : C28H40N6O
纯度 : 98+%
分子量 : 476.657
MDL号 : MFCD28142874
存储条件:

粉末 Sealed in dry,2-8°C

液体 -20°C:3-6个月-80°C:12个月

溶解度 :

DMSO: 105 mg/mL(220.28 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

动物实验配方:
生物活性
描述 Mer, Tyro and Axl are members of the TAM subfamily of receptor tyrosine kinases (RTK). FLT3 belongs to type Ⅲ RTKs. Containing an extracellular domain for ligand binding and intracellular kinase domains that mediate autophosphorylation, recruitment of downstream signaling molecules, and signal transduction, RTKs are mediators of cellular proliferation. UNC2025 is a Mer and FLT3 dual inhibitor. The inhibitory IC50s of UNC2025 against Mer and FLT3 kinase were 0.8 nM and 0.74 nM, respectively, and the Kis were 0.16 nM and 0.59 nM, respectively. In B-ALL 697 cells, UNC2025 inhibited Mer phosphorylation with an IC50 of 2.7 nM and in Molm-14 cells, UNC2025 decreased FLT3 phosphorylation with an IC50 of 14 nM. UNC2025 dose-dependently inhibited colony formation of A549 cells at the concentrations of 50, 100, and 300 nM, and that of Molm-14 cells at the concentrations of 10, 25, and 50 nM[3]. 72h treatment of 300 nM UNC2025 induced apoptosis in NSCLC H2228, A549, Colo699 and H1299 cells[4]. In NSG mice transplanted with B-ALL cells by i.v. injection, a single dose of UNC2025 (3 mg/kg) administrated orally was sufficient to decrease Merphospho-protein levels in bone marrow leukemia cells by greater than 90%[3]. In H2228 or A549 xenografts established in nude mice, UNC2025 administrated at the dose of 50 mg/kg twice daily by oral gavage reduced tumor volume by 70.2% and 61.9%, respectively[4].
作用机制 UNC2025 inhibited Mer and FLT3 kinase activity in an ATP competitive manner.
细胞研究
细胞系 浓度 检测类型 检测时间 活动说明 数据源
32D cells Function assay 1 h Inhibition of EGFR extracellular/transmembrane domain-tagged Mer intracellular domain (unknown origin) expressed in 32D cells assessed as inhibition EGF-stimulated of phosphorylation pretreated for 1 hr prior to EGF stimulation by Western blot analysis, IC50=2.7 nM 25068800
697 cells Function assay 1 h Inhibition of Mer phosphorylation in human 697 cells preincubated for 1 hr by densitometry, IC50=2.7 nM 25068800
A549 cells 50-300 nM Function assay Inhibition of Mer-mediated colony formation in human A549 cells at 50 to 300 nM measured after 2 weeks by soft agar colony formation assay 25068800
实验方案
1mg 5mg 10mg

1 mM

5 mM

10 mM

2.10mL

0.42mL

0.21mL

10.49mL

2.10mL

1.05mL

20.98mL

4.20mL

2.10mL

参考文献

[1]Branchford BR, Stalker TJ, et al. The small molecule MERTK inhibitor UNC2025 decreases platelet activation and prevents thrombosis. J Thromb Haemost. 2017 Oct 17.

[2]Zhang W, DeRyckere D, et al. UNC2025, a potent and orally bioavailable MER/FLT3 dual inhibitor. J Med Chem. 2014 Aug 28;57(16):7031-41.

[3]Zhang W, DeRyckere D, Hunter D, Liu J, Stashko MA, Minson KA, Cummings CT, Lee M, Glaros TG, Newton DL, Sather S, Zhang D, Kireev D, Janzen WP, Earp HS, Graham DK, Frye SV, Wang X. UNC2025, a potent and orally bioavailable MER/FLT3 dual inhibitor. J Med Chem. 2014 Aug 28;57(16):7031-41. doi: 10.1021/jm500749d. Epub 2014 Aug 6. PMID: 25068800; PMCID: PMC4148167.

[4]Cummings CT, Zhang W, Davies KD, Kirkpatrick GD, Zhang D, DeRyckere D, Wang X, Frye SV, Earp HS, Graham DK. Small Molecule Inhibition of MERTK Is Efficacious in Non-Small Cell Lung Cancer Models Independent of Driver Oncogene Status. Mol Cancer Ther. 2015 Sep;14(9):2014-22. doi: 10.1158/1535-7163.MCT-15-0116. Epub 2015 Jul 10. PMID: 26162689; PMCID: PMC4704683.